After normalization of the other clinical features (including TNM stage), only HOXA1 and HOXA3 expression was still associated with poor OS of cervical cancer, indicative of the fact that these two HOXA members could serve as independent predictive biomarkers of cervical cancer (Tables 2 and 3). This evidence concerns the gene HOXA3 and cervical carcinoma.